haloperidol has been researched along with Diabetes Mellitus in 15 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol (HL) has successfully been used for nausea and abdominal pain in emergency departments (EDs)." | 8.02 | Haloperidol Use in the Emergency Department for Gastrointestinal Symptoms: Nausea, Vomiting, and Abdominal Pain. ( Jehangir, A; Malik, Z; Parkman, HP; Repanshek, ZD; Reznick-Lipina, K; Shahsavari, D; Weiner, M, 2021) |
| "Pharmacovigilance survey of spontaneously reported adverse events in risperidone-treated patients, with reports of haloperidol-associated hyperglycemia used as a control." | 7.72 | Risperidone-associated diabetes mellitus: a pharmacovigilance study. ( Cross, JT; Doraiswamy, PM; Koller, EA; Schneider, BS, 2003) |
| "Medication-naïve patients with schizophrenia (n = 99) underwent baseline fasting and 2 h post-prandial plasma glucose measurements repeated after 6 weeks after randomization to receive olanzapine, risperidone or haloperidol." | 5.13 | Diabetes and schizophrenia - effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia. ( Akhtar, S; Ameen, S; Manjunatha, N; Saddichha, S, 2008) |
| "Haloperidol (HL) has successfully been used for nausea and abdominal pain in emergency departments (EDs)." | 4.02 | Haloperidol Use in the Emergency Department for Gastrointestinal Symptoms: Nausea, Vomiting, and Abdominal Pain. ( Jehangir, A; Malik, Z; Parkman, HP; Repanshek, ZD; Reznick-Lipina, K; Shahsavari, D; Weiner, M, 2021) |
| "The use of clozapine and other antipsychotic drugs is known to be associated with a number of adverse metabolic side effects, including diabetes mellitus." | 3.79 | Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: role of FOXA1 and mitochondrial citrate carrier. ( Convertini, P; Iacobazzi, F; Iacobazzi, V; Infantino, V; Menga, A; Palmieri, F, 2013) |
| "Pharmacovigilance survey of spontaneously reported adverse events in risperidone-treated patients, with reports of haloperidol-associated hyperglycemia used as a control." | 3.72 | Risperidone-associated diabetes mellitus: a pharmacovigilance study. ( Cross, JT; Doraiswamy, PM; Koller, EA; Schneider, BS, 2003) |
| "To examine quantitatively the association between glucose intolerance including diabetes mellitus and the use of the atypical antipsychotics clozapine, olanzapine or risperidone, and to identify possible risk factors for the development of glucose intolerance during treatment with these drugs." | 3.71 | Glucose intolerance with atypical antipsychotics. ( Hägg, S; Hedenmalm, K; Mortimer, O; Spigset, O; Ståhl, M, 2002) |
| "Hemichorea is a disorder characterized by abnormal, continuous, nonrhythmic, jerky, and distal movement involving one side of the body." | 1.43 | Hemichorea with unilateral MRI striatal hyperintensity in a Saudi patient with diabetes. ( Al-Quliti, KW; Assaedi, ES, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Shahsavari, D | 1 |
| Reznick-Lipina, K | 1 |
| Malik, Z | 1 |
| Weiner, M | 1 |
| Jehangir, A | 1 |
| Repanshek, ZD | 1 |
| Parkman, HP | 1 |
| Al-Quliti, KW | 1 |
| Assaedi, ES | 1 |
| Nishtala, PS | 1 |
| Chyou, TY | 1 |
| Menga, A | 1 |
| Infantino, V | 1 |
| Iacobazzi, F | 1 |
| Convertini, P | 1 |
| Palmieri, F | 1 |
| Iacobazzi, V | 1 |
| Hedenmalm, K | 1 |
| Hägg, S | 1 |
| Ståhl, M | 1 |
| Mortimer, O | 1 |
| Spigset, O | 1 |
| Gupta, S | 1 |
| Koller, EA | 1 |
| Cross, JT | 1 |
| Doraiswamy, PM | 1 |
| Schneider, BS | 1 |
| Dunlop, BW | 1 |
| Sternberg, M | 1 |
| Phillips, LS | 1 |
| Andersen, J | 1 |
| Duncan, E | 1 |
| Mosolov, SN | 1 |
| Kabanov, SO | 1 |
| Nagai, C | 1 |
| Lautar, SL | 1 |
| Rojas, C | 1 |
| Slusher, BS | 1 |
| Wozniak, KM | 1 |
| Wu, Y | 1 |
| Thomas, AG | 1 |
| Waldon, D | 1 |
| Li, W | 1 |
| Ferraris, D | 1 |
| Belyakov, S | 1 |
| Guha, P | 1 |
| Roy, K | 1 |
| Sanyal, D | 1 |
| Dasgupta, T | 1 |
| Bhattacharya, K | 1 |
| Saddichha, S | 1 |
| Manjunatha, N | 1 |
| Ameen, S | 1 |
| Akhtar, S | 1 |
| Billington, CJ | 1 |
| Morley, JE | 1 |
| Levine, AS | 1 |
| Gerritsen, GC | 1 |
| Iwata, A | 1 |
| Koike, F | 1 |
| Arasaki, K | 1 |
| Tamaki, M | 1 |
3 reviews available for haloperidol and Diabetes Mellitus
| Article | Year |
|---|---|
Safety in treating bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Diabetes Melli | 2003 |
[The appearance of metabolic syndrome in treatment with atypical antipsychotics].
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body W | 2003 |
[Progress in diagnosis of and therapy for diabetic choreic movement and ballismus].
Topics: Anti-Dyskinesia Agents; Basal Ganglia; Chorea; Diabetes Complications; Diabetes Mellitus; Dyskinesia | 2004 |
2 trials available for haloperidol and Diabetes Mellitus
| Article | Year |
|---|---|
Olanzapine-induced obesity and diabetes in Indian patients: a prospective trial comparing olanzapine with typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Diabetes | 2005 |
Diabetes and schizophrenia - effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus; Dose-Response Relationship, Drug; D | 2008 |
10 other studies available for haloperidol and Diabetes Mellitus
| Article | Year |
|---|---|
Haloperidol Use in the Emergency Department for Gastrointestinal Symptoms: Nausea, Vomiting, and Abdominal Pain.
Topics: Abdominal Pain; Adult; Antiemetics; Diabetes Mellitus; Emergency Service, Hospital; Female; Florida; | 2021 |
Hemichorea with unilateral MRI striatal hyperintensity in a Saudi patient with diabetes.
Topics: Anti-Dyskinesia Agents; Chorea; Diabetes Complications; Diabetes Mellitus; Female; Haloperidol; Huma | 2016 |
Real-world risk of diabetes with antipsychotic use in older New Zealanders: a case-crossover study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Diabetes Mellitus; Female; Haloperidol; Humans; Male; | 2017 |
Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: role of FOXA1 and mitochondrial citrate carrier.
Topics: Anion Transport Proteins; Antipsychotic Agents; Cell Line; Clozapine; Diabetes Mellitus; Gene Expres | 2013 |
Glucose intolerance with atypical antipsychotics.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Chlor | 2002 |
Risperidone-associated diabetes mellitus: a pharmacovigilance study.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; An | 2003 |
Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Cohort Studies; Depressive Disorder; Diabetes | 2003 |
DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice.
Topics: Amphetamine; Animals; Aza Compounds; Azetidines; Behavior, Animal; Diabetes Mellitus; Dipeptidyl-Pep | 2005 |
Feeding systems in Chinese hamsters.
Topics: Animals; Brain; Calcitonin; Circadian Rhythm; Cricetinae; Cyclazocine; Diabetes Mellitus; Dynorphins | 1984 |
Blood brain barrier destruction in hyperglycemic chorea in a patient with poorly controlled diabetes.
Topics: Anti-Dyskinesia Agents; Basal Ganglia; Blood-Brain Barrier; Chorea; Corpus Striatum; Cysteine; Diabe | 1999 |